Medmira Stock Performance
| MIR Stock | CAD 0.10 0.01 9.09% |
On a scale of 0 to 100, MedMira holds a performance score of 7. The company secures a Beta (Market Risk) of 0.8, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MedMira's returns are expected to increase less than the market. However, during the bear market, the loss of holding MedMira is expected to be smaller as well. Please check MedMira's information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis , to make a quick decision on whether MedMira's current price movements will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in MedMira are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, MedMira showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | MedMira Gains Health Canada Approval for Rapid Test - MSN | 12/24/2024 |
2 | MedMira Receives Investigational Testing Authorization for its Multiplo Complete Syphilis Antibody Test - Barchart | 01/09/2025 |
3 | MedMira Receives Investigational Testing Authorizations for Multiplo TPHIV Self-Test and Non-Professional Use Applications - sharewise | 01/22/2025 |
4 | MedMira Announces Partnership with MediGroup Physician Services in the United States - Yahoo Finance | 02/27/2025 |
| Begin Period Cash Flow | 13.2 K |
MedMira |
MedMira Relative Risk vs. Return Landscape
If you would invest 8.00 in MedMira on December 10, 2024 and sell it today you would earn a total of 2.00 from holding MedMira or generate 25.0% return on investment over 90 days. MedMira is currently producing 0.5548% returns and takes up 6.2135% volatility of returns over 90 trading days. Put another way, 55% of traded stocks are less volatile than MedMira, and 89% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
MedMira Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedMira's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MedMira, and traders can use it to determine the average amount a MedMira's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0893
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MIR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.21 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.55 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average MedMira is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MedMira by adding it to a well-diversified portfolio.
MedMira Fundamentals Growth
MedMira Stock prices reflect investors' perceptions of the future prospects and financial health of MedMira, and MedMira fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MedMira Stock performance.
| Return On Asset | -0.26 | ||||
| Operating Margin | (7.40) % | ||||
| Current Valuation | 82.16 M | ||||
| Shares Outstanding | 701.73 M | ||||
| Price To Earning | (5.00) X | ||||
| Price To Sales | 206.72 X | ||||
| Revenue | 412.57 K | ||||
| Gross Profit | (512.51 K) | ||||
| EBITDA | (2.12 M) | ||||
| Net Income | (3.33 M) | ||||
| Cash And Equivalents | 1.06 K | ||||
| Total Debt | 6.11 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (2.94 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 56.14 M | ||||
| Total Asset | 6.07 M | ||||
| Retained Earnings | (101.29 M) | ||||
| Working Capital | (17.28 M) | ||||
About MedMira Performance
Evaluating MedMira's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if MedMira has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MedMira has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 401.60 | 381.52 | |
| Return On Tangible Assets | (0.49) | (0.52) | |
| Return On Capital Employed | 0.16 | 0.13 | |
| Return On Assets | (0.49) | (0.52) | |
| Return On Equity | 0.21 | 0.20 |
Things to note about MedMira performance evaluation
Checking the ongoing alerts about MedMira for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MedMira help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MedMira is way too risky over 90 days horizon | |
| MedMira has some characteristics of a very speculative penny stock | |
| MedMira appears to be risky and price may revert if volatility continues | |
| MedMira has high likelihood to experience some financial distress in the next 2 years | |
| MedMira has accumulated 6.11 M in total debt. MedMira has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MedMira until it has trouble settling it off, either with new capital or with free cash flow. So, MedMira's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MedMira sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MedMira to invest in growth at high rates of return. When we think about MedMira's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 412.57 K. Net Loss for the year was (3.33 M) with loss before overhead, payroll, taxes, and interest of (512.51 K). | |
| MedMira has accumulated about 1.06 K in cash with (2.94 M) of positive cash flow from operations. | |
| Roughly 69.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: MedMira Announces Partnership with MediGroup Physician Services in the United States - Yahoo Finance |
- Analyzing MedMira's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MedMira's stock is overvalued or undervalued compared to its peers.
- Examining MedMira's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MedMira's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MedMira's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MedMira's stock. These opinions can provide insight into MedMira's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.